Vaccines and Diagnostics

The Novartis Vaccines and Diagnostics Division provides more than 20 vaccines to prevent viral and bacterial diseases, as well as sophisticated instruments, assays and software to protect the blood supply from the spread of infections.

The division consists of two businesses - Novartis Vaccines and Novartis Diagnostics, the blood testing business.

 

Novartis Vaccines

Novartis Vaccines is dedicated to delivering on the promise of prevention through the research, development and production of innovative, safe and effective vaccines. At the heart of everything we do is our commitment to preventing the spread of life-threatening diseases, protecting vulnerable populations, and keeping healthy people healthy.

By focusing on disease prevention, Novartis Vaccines plays a key role in the company's core mission: keeping people healthy, alleviating suffering and enhancing quality of life.
The current vaccine portfolio includes vaccines to prevent:

• Influenza
• Meningitis
• Rabies
• Japanese encephalitis
• Tick-borne encephalitis
• Haemophilus Influenzae type B (Hib)
• Polio
• Diphtheria
• Tetanus
• Pertussis (whooping cough)

Learn more on the Novartis Vaccines website

 

Novartis Diagnostics: the blood testing business

Building on more than a decade of dedication to blood safety, Novartis Diagnostics is developing a future of innovative solutions for preventive screening and the prediction of health outcomes.
Novartis Diagnostics products are used to test millions of blood donations around the world each year for pathogens such as HIV (the AIDS virus), hepatitis B and hepatitis C, and West Nile virus.

More than 80 percent of the US blood supply is tested on Novartis Diagnostics systems to ensure safety for transfusion or use in other blood products.

Visit the Novartis Diagnostics website